The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 14, 2023
Filed:
Jul. 27, 2022
Applicant:
Zhejiang Shimai Pharmaceutical Co., Ltd., Zhejiang, CN;
Inventors:
Zuoxiang XIao, Zhejiang, CN;
Jiaping Peng, Zhejiang, CN;
Dongwen Zhou, Zhejiang, CN;
Wei Zhou, Zhejiang, CN;
Assignee:
Zhejiang Shimai Pharmaceutical Co., Ltd., Hangzhou, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/40 (2006.01); C07K 16/28 (2006.01); A61K 47/68 (2017.01); A61K 45/06 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 47/6803 (2017.08); A61K 47/6871 (2017.08); C07K 16/2809 (2013.01); C07K 16/40 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/732 (2013.01);
Abstract
Disclosed herein are antibodies against ENPP3 and uses thereof, specifically monoclonal antibodies against ENPP3, bispecific antibodies against ENPP3 and CD3, nucleic acids including nucleotide sequences encoding the antibodies, vectors including the nucleic acids, and host cell including the nucleic acids or the vectors. Also disclosed are pharmaceutical compositions and conjugates including the antibodies, and therapeutic methods for using the antibodies.